HCV and Diabetes: Towards a ‘Sustained’ Glycaemic Improvement After Treatment With DAAs? – Authors' Reply

Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2016.12.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

HCV and Diabetes: Towards a ‘Sustained’ Glycaemic Improvement After Treatment With DAAs?

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2017English

Letter: HCV Complication and Type 2 Diabetes Management-The Directional Link Is Not Yet Defined. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Sugar Consumption and Diabetes (The Authors Reply)

Journal of Chemical Education
ChemistryEducation
1933English

Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders

BMC Infectious Diseases
Infectious Diseases
2020English

Monitoring Lithium Treatment: Authors' Reply

BMJ
1993English

Authors’ Reply Re: Towards Painless and Adhesion‐free Laparoscopy

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2019English

Significant Improvement of Glycaemic Control in Diabetic Patients With HCV Infection Responding to Direct-Acting Antiviral Agents

Journal of Medical Virology
VirologyInfectious Diseases
2017English

Neuropsychiatric Outcomes After Stroke – Authors' Reply

The Lancet Neurology
Neurology
2014English

Systemic Adipokines, Hepatokines and Interleukin-6 in HCV-monoinfected and HCV/HIV Coinfected Patients Treated With Direct Antiviral Agents (DAAs)

Clinics and Research in Hepatology and Gastroenterology
HepatologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy